Abstract
Objective. To explore barriers in the health service to diagnosis and treatment experienced by women at increased risk of coronary heart disease (CHD). Design. Qualitative study using semi-structured interviews. Setting. Norway. Subjects. Twenty women diagnosed with heterozygous familial hypercholesterolemia (FH) recruited through a lipid clinic. Results. Women reported three specific barriers related to diagnosis and treatment of CHD. They had to struggle to take a cholesterol test; they experienced that their risk was being downplayed by doctors; and that their symptoms of CHD were misinterpreted when they consulted doctors for evaluation and treatment. Conclusion. Stereotyping CHD as a man's disease may result in barriers to diagnosis and treatment for women. Doctors should ask the patient about the family history of CHD if a concern about heart disease is on the patient's agenda.